LDN for MS

Clinical research showing the benefits of LDN for MS!

Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.

Let me know what's on your mind!

This site uses Akismet to reduce spam. Learn how your comment data is processed.